CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin

Published:2015-10-09 Issue:2 Volume:35 Page:163-171
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Shibata Yuhei¹,Hara Takeshi¹,Kasahara Senji²,Yamada Toshiki³,Sawada Michio⁴,Mabuchi Ryoko¹⁵,Matsumoto Takuro¹,Nakamura Nobuhiko¹,Nakamura Hiroshi¹,Ninomiya Soranobu¹,Kitagawa Junichi¹,Kanemura Nobuhiro¹,Kito Yusuke⁶,Goto Naoe¹,Miyazaki Tatsuhiko⁷,Takami Tsuyoshi⁶,Takeuchi Tamotsu⁶,Shimizu Masahito¹,Tsurumi Hisashi¹

Affiliation:

1. Department of Hematology; Gifu University Graduate School of Medicine; Gifu Japan

2. Department of Hematology; Gifu Municipal Hospital; Gifu Japan

3. Department of Hematology; Gifu Prefectural General Medical Center; Gifu Japan

4. Department of Hematology; Japanese Red Cross Gifu Hospital; Gifu Japan

5. Department of Internal Medicine; Kisogawa Municipal Hospital; Gifu Japan

6. Department of Pathology and Translational Research; Gifu University Graduate School of Medicine; Gifu Japan

7. Pathology Division; Gifu University Hospital; Gifu Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2262/fullpdf

Reference46 articles.

1. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's lymphoma classification project;Anderson;Ann Oncol,1998

2. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Vose;J Clin Oncol,2008

3. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management;Armitage;Am J Hematol,2012

4. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States;Abouyabis;Leuk Lymphoma,2008

5. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience;Escalón;Cancer,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study;Hematological Oncology;2022-07-08

2. Serum miR-21 predicts the prognosis of patients with primary gastrointestinal diffuse large B-cell lymphoma;Acta Biochimica Polonica;2022-06-12

3. Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry;International Journal of Hematology;2021-04-16

4. Anti-fibrosis potential of pirarubicin via inducing apoptotic and autophagic cell death in rabbit conjunctiva;Experimental Eye Research;2020-11

5. MicroRNA‐129‐1‐3p protects cardiomyocytes from pirarubicin‐induced apoptosis by down‐regulating the GRIN2D‐mediated Ca 2+ signalling pathway;Journal of Cellular and Molecular Medicine;2020-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3